Acasti Pharma Inc. reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported net loss was USD 4.52 million compared to USD 3.12 million a year ago. Basic loss per share from continuing operations was USD 0.6 compared to USD 0.72 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.729 USD | +1.12% | +0.33% | -5.57% |
May. 28 | Acasti Pharma Inc. to Attend BIO International Convention 2024 | CI |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.57% | 25.65M | |
+40.73% | 739B | |
+31.84% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.94% | 240B | |
+9.47% | 210B | |
-4.95% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Acasti Pharma Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022